Assessing meaningful change in quality of life over time: A users' guide for clinicians

被引:120
作者
Sprangers, MAG
Moinpour, CM
Moynihan, TJ
Patrick, DL
Revicki, DA
机构
[1] Univ Amsterdam, Acad Med Ctr, Dept Psychol Med, NL-1105 AZ Amsterdam, Netherlands
[2] SW Oncol Grp, Stat Ctr, Seattle, WA USA
[3] Mayo Clin & Mayo Fdn, Div Med Oncol, Rochester, MN 55905 USA
[4] Univ Washington, Dept Hlth Sci, Seattle, WA 98195 USA
[5] MEDTAP Int Inc, Ctr Hlth Outcomes Res, Bethesda, MD USA
关键词
D O I
10.4065/77.6.561
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The objective of this article is to help clinicians interpret trial-based quality of life (QOL) changes over time. We address a series of questions and provide guidelines that are fundamental to assessing and interpreting change. The issues addressed are as follows: (1) What are the characteristics of the population for whom changes in QOL are reported? (2) Is the QOL questionnaire reliable, valid, and responsive to change? (3) Are the timing and frequency of assessments adequate? (4) Is the study adequately powered? (5) How are multiple QOL outcomes addressed in analyses? (6) How are multiple time points handled? (7) Can alternative explanations account for the observed change or lack of observed change (eg, handling of missing data, survival differences, and changes in patient's QOL perspective over time)? and (8) How is statistical significance translated into meaningful change? These guidelines will support clinicians in reviewing the clinical trial literature, which in turn can help them use the data in the treatment decision process.
引用
收藏
页码:561 / 571
页数:11
相关论文
共 74 条
[1]   THE EUROPEAN-ORGANIZATION-FOR-RESEARCH-AND-TREATMENT-OF-CANCER QLQ-C30 - A QUALITY-OF-LIFE INSTRUMENT FOR USE IN INTERNATIONAL CLINICAL-TRIALS IN ONCOLOGY [J].
AARONSON, NK ;
AHMEDZAI, S ;
BERGMAN, B ;
BULLINGER, M ;
CULL, A ;
DUEZ, NJ ;
FILIBERTI, A ;
FLECHTNER, H ;
FLEISHMAN, SB ;
DEHAES, JCJM ;
KAASA, S ;
KLEE, M ;
OSOBA, D ;
RAZAVI, D ;
ROFE, PB ;
SCHRAUB, S ;
SNEEUW, K ;
SULLIVAN, M ;
TAKEDA, F .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1993, 85 (05) :365-376
[2]   PROTON NMR-STUDY OF MOLECULAR-MOTION IN SOLID CORTISONE [J].
ANDREW, ER ;
KEMPKA, M .
SOLID STATE NUCLEAR MAGNETIC RESONANCE, 1993, 2 (05) :261-264
[3]  
[Anonymous], ADAPTATION CHANGING
[4]  
[Anonymous], 1997, CLIN TRIALS ONCOLOGY
[5]   LIFE SATISFACTION AND WELL-BEING MEASURES IN VENTILATOR ASSISTED INDIVIDUALS WITH TRAUMATIC TETRAPLEGIA [J].
BACH, JR ;
TILTON, MC .
ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION, 1994, 75 (06) :626-632
[6]   Understanding changes in health status - Is the floor phenomenon merely the last step of the staircase? [J].
Baker, DW ;
Hays, RD ;
Brook, RH .
MEDICAL CARE, 1997, 35 (01) :1-15
[7]  
Bennett KJ, 1996, QUALITY LIFE PHARMAC, P253
[8]   Quality of life as subjective experience:: Reframing of perception in patients with colon cancer undergoing radical resection with or without adjuvant chemotherapy [J].
Bernhard, J ;
Hürny, C ;
Maibach, R ;
Herrmann, R ;
Laffer, U .
ANNALS OF ONCOLOGY, 1999, 10 (07) :775-782
[9]   A COMPARISON OF HEALTH-RELATED QUALITY-OF-LIFE MEASURES FOR RHEUMATOID-ARTHRITIS RESEARCH [J].
BOMBARDIER, C ;
RABOUD, J .
CONTROLLED CLINICAL TRIALS, 1991, 12 (04) :S243-S256
[10]   Group vs individual approaches to understanding the clinical significance of differences or changes in quality of life [J].
Cella, D ;
Bullinger, M ;
Scott, C ;
Barofsky, I .
MAYO CLINIC PROCEEDINGS, 2002, 77 (04) :384-392